In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 891782-60-8, name is 7-Bromo-3,4-dihydro-2H-isoquinolin-1-one, introducing its new discovery. category: isoquinoline
The invention relates to a large-position electron-deficient organic phosphine ligand compound, and more specifically relates to a compound with (1 – (a structure) represented by) – any (3 one 5 – of (the following formulas)), namely, an acenaphthenaphthenaphthenaphenaphthenaphenaphthoxygenin-soldien and a synthesis method thereof. The large-position electron-deficient organic phosphine ligand compound synthesized by taking acenaphthene as a skeleton has a plurality of modification sites, is abundant in structure, can be stably found in air, is easily available in synthesis raw materials and simple in synthesis method, and can be used as an important ligand in the field of palladium catalysts. (by machine translation)
We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 891782-60-8, and how the biochemistry of the body works.category: isoquinoline
Reference：
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem